prof. dr. apr. Evelyne Meyer
- ORCID iD
-
0000-0002-7066-8255
Show
Sort by
-
Clinical implementation of an engineered lysin in veterinary dermatology
-
Clinical implementation of an engineered lysin in veterinary dermatology
-
Flow cytometry for quantitative cytotoxicity and safety assessment in bovine mammospheres : applied to a novel bacteriophage-derived engineered lysin
-
Triple-target blockade of CHI3L1, LCN2, and PD-L1 reduces tumor growth and enhances immunostimulation in a mouse TNBC model
-
- Journal Article
- A1
- open access
Grade III canine and feline mammary carcinomas are associated with an immunosuppressed, vascularized and proliferative microenvironment
-
G-CSF-overexpression induces an inflammatory tumor microenvironment in mouse TNBC models with targetable upregulation of LCN2 and CHI3L1
-
- Journal Article
- A1
- open access
Influence of carcinoma and sarcoma on neutrophil gelatinase-associated lipocalin and symmetric dimethylarginine concentrations in dogs
-
- Journal Article
- A1
- open access
Canine organoids : state-of-the-art, translation potential for human medicine and plea for standardization
-
- Journal Article
- A1
- open access
CD94 as a novel marker for immunophenotyping of leukemia and lymphoma in dogs
-
- Miscellaneous
- open access
Targeting ferroptosis protects against experimental (multi)organ dysfunction and death (vol 13, 1046, 2025)